{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-22-001222","form_type":"8-K","ticker":"VANI","cik":"0001266806","company_name":"Vivani Medical, Inc.","filed_at":"2022-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.194978+00:00","generated_at":"2026-06-23T16:14:46.142266+00:00","sec_items":["1.01","2.01","5.01","5.02","5.03","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Vivani (fka Second Sight) completes merger with Nano Precision Medical; ticker changes to VANI","bullets":["Closed merger with NPM on Aug 30, 2022; issued 37.6M shares to NPM holders, giving them ~74.1% ownership.","Name changed to Vivani Medical; common stock begins trading under VANI; warrants VANIW to be delisted.","Board reduced to five; Adam Mendelsohn appointed CEO; new C-suite includes Brigid Makes (CFO), Truc Le (COO).","Pro forma cash ~$55M; lead drug implant NPM-119 for Type 2 diabetes expected to begin clinical evaluation by end of 2022.","NPM's unaudited H1 2022 net loss $8.0M on zero revenue; cash and equivalents $3.45M as of June 30, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-22-001222","json":"https://secwatch.observer/filing/0001753926-22-001222.json","markdown":"https://secwatch.observer/filing/0001753926-22-001222.md","text":"https://secwatch.observer/filing/0001753926-22-001222.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/g083173_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T16:14:46.142266+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f9c8eaf9e","claim":"Lisa Porter was appointed as Chief Medical Officer at Vivani Medical, Inc..","evidence_excerpt":"As of the Effective Time, the Board appointed Adam Mendelsohn, as Chief Executive Officer of the Company, Brigid A. Makes, as Chief Financial Officer of the Company, Truc Le, as Chief Operating Officer of the Company, Donald Dwyer, as Chief Business Officer of the Company, and Lisa Porter, as Chief Medical Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"2fea5c4742","claim":"Adam Mendelsohn was appointed as Director at Vivani Medical, Inc..","evidence_excerpt":"On and as of the Effective Date, the Board appointed Adam Mendelsohn as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3c9fe40843","claim":"Scott Dunbar resigned as Acting Chief Executive Officer at Vivani Medical, Inc..","evidence_excerpt":"Scott Dunbar, Company’s Acting Chief Executive Officer and Edward Sedo, the Company’s Acting Chief Accounting Officer, resigned as officers of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Acting Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"4a07ba57a4","claim":"Donald Dwyer was appointed as Chief Business Officer at Vivani Medical, Inc..","evidence_excerpt":"As of the Effective Time, the Board appointed Adam Mendelsohn, as Chief Executive Officer of the Company, Brigid A. Makes, as Chief Financial Officer of the Company, Truc Le, as Chief Operating Officer of the Company, Donald Dwyer, as Chief Business Officer of the Company, and Lisa Porter, as Chief Medical Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Business Officer"}],"fact_type":"executive_change"},{"claim_id":"51c3c7efb2","claim":"Matthew Pfeffer resigned as Director at Vivani Medical, Inc..","evidence_excerpt":"Pursuant to the Merger Agreement, immediately prior to and effective upon the Merger, Jonathan Will McGuire and Matthew Pfeffer, resigned from the Board and any respective committees of the Board to which they belonged, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices .","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"69f23f01ed","claim":"Edward Sedo resigned as Acting Chief Accounting Officer at Vivani Medical, Inc..","evidence_excerpt":"Scott Dunbar, Company’s Acting Chief Executive Officer and Edward Sedo, the Company’s Acting Chief Accounting Officer, resigned as officers of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Acting Chief Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"775d125069","claim":"Truc Le was appointed as Chief Operating Officer at Vivani Medical, Inc..","evidence_excerpt":"As of the Effective Time, the Board appointed Adam Mendelsohn, as Chief Executive Officer of the Company, Brigid A. Makes, as Chief Financial Officer of the Company, Truc Le, as Chief Operating Officer of the Company, Donald Dwyer, as Chief Business Officer of the Company, and Lisa Porter, as Chief Medical Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"82c89ea1a7","claim":"Brigid A. Makes was appointed as Chief Financial Officer at Vivani Medical, Inc..","evidence_excerpt":"As of the Effective Time, the Board appointed Adam Mendelsohn, as Chief Executive Officer of the Company, Brigid A. Makes, as Chief Financial Officer of the Company, Truc Le, as Chief Operating Officer of the Company, Donald Dwyer, as Chief Business Officer of the Company, and Lisa Porter, as Chief Medical Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"b387607ec3","claim":"Jonathan Will McGuire resigned as Director at Vivani Medical, Inc..","evidence_excerpt":"Pursuant to the Merger Agreement, immediately prior to and effective upon the Merger, Jonathan Will McGuire and Matthew Pfeffer, resigned from the Board and any respective committees of the Board to which they belonged, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices .","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d852d97e1e","claim":"Adam Mendelsohn was appointed as Chief Executive Officer at Vivani Medical, Inc..","evidence_excerpt":"As of the Effective Time, the Board appointed Adam Mendelsohn, as Chief Executive Officer of the Company, Brigid A. Makes, as Chief Financial Officer of the Company, Truc Le, as Chief Operating Officer of the Company, Donald Dwyer, as Chief Business Officer of the Company, and Lisa Porter, as Chief Medical Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001222/0001753926-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}